association

Full identifier: http://purl.org/np/RA9sZYKH0Ol0uxtn9sevWwFASD6uz6PK-2uMPkOfDiaeI#association

Assigned to 1 class:

Minted in Nanopublication

 RA9sZYKH0O comment approve/disapprove edit as derived nanopublication create new with same template

This is a local identifier minted within the nanopublication. http://purl.org/np/RA9sZYKH0O...#association This association http://www.w3.org/2000/01/rdf-schema#label has label (this is a literal) "intravenous administration is usually reserved for life threatening arrhythmias or those occurring under anesthesia 1 supraventricular arrhythmia intravenous propranolol is indicated for the short term treatment of supraventricular tachycardia including wolff parkinson white syndrome and thyrotoxicosis to decrease ventricular rate use in patients with atrial flutter or atrial fibrillation should be reserved for arrythmias unresponsive to standard therapy or when more prolonged control is required reversion to normal sinus rhythm has occasionally been observed predominantly in patients with sinus or atrial tachycardia 2 ventricular tachycardias with the exception of those induced by catecholamines or digitalis propranolol is not the drug of first choice in critical situations when cardioversion techniques or other drugs are not indicated or are not effective propranolol may be considered if after consideration of the risks involved propranolol is used it should be given intravenously in low dosage and very slowly as the failing heart requires some sympathetic drive for maintenance of myocardial tone see dosage and administration some patients may respond with complete reversion to normal sinus rhythm but reduction in ventricular rate is more likely ventricular arrhythmias do not respond to propranolol as predictably as do the supraventricular arrhythmias intravenous propranolol is indicated for the treatment of persistent premature ventricular extrasystoles that impair the well being of the patient and do not respond to conventional measures 3 tachyarrhythmias of digitalis intoxication intravenous propranolol is indicated to control ventricular rate in life threatening digitalis induced arrhythmias severe bradycardia may occur see overdosage 4 resistant tachyarrhythmias due to excessive catecholamine action during anesthesia intravenous propranolol is indicated to abolish tachyarrhythmias due to excessive catecholamine action during anesthesia when other measures fail these arrhythmias may arise because of release of endogenous catecholamines or administration of catecholamines all general inhalation anesthetics produce some degree of myocardial depression therefore when propranolol is used to treat arrhythmias during anesthesia it should be used with extreme caution usually with constant monitoring of the ecg and central venous pressure see warnings" .
This is the identifier for this whole nanopublication. http://purl.org/np/RA9sZYKH0O... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal) "2021-06-15T17:54:05.390+02:00" .
This is the identifier for this whole nanopublication. http://purl.org/np/RA9sZYKH0O... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAManV5GZI... RAManV5GZI .
This is the identifier for this whole nanopublication. http://purl.org/np/RA9sZYKH0O... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW... RANwQa4ICW .
This is the identifier for this whole nanopublication. http://purl.org/np/RA9sZYKH0O... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC... RAA2MfqdBC .

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-15T15:54:05.390Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
intravenous administration is usually reserved for life threatening arrhythmias or those occurring under anesthesia 1 supraventricular arrhythmia intravenous propranolol is indicated for the short term treatment of supraventricular tachycardia including wolff parkinson white syndrome and thyrotoxicosis to decrease ventricular rate use in patients with atrial flutter or atrial fibrillation should be reserved for arrythmias unresponsive to standard therapy or when more prolonged control is required reversion to normal sinus rhythm has occasionally been observed predominantly in patients with sinus or atrial tachycardia 2 ventricular tachycardias with the exception of those induced by catecholamines or digitalis propranolol is not the drug of first choice in critical situations when cardioversion techniques or other drugs are not indicated or are not effective propranolol may be considered if after consideration of the risks involved propranolol is used it should be given intravenously in low dosage and very slowly as the failing heart requires some sympathetic drive for maintenance of myocardial tone see dosage and administration some patients may respond with complete reversion to normal sinus rhythm but reduction in ventricular rate is more likely ventricular arrhythmias do not respond to propranolol as predictably as do the supraventricular arrhythmias intravenous propranolol is indicated for the treatment of persistent premature ventricular extrasystoles that impair the well being of the patient and do not respond to conventional measures 3 tachyarrhythmias of digitalis intoxication intravenous propranolol is indicated to control ventricular rate in life threatening digitalis induced arrhythmias severe bradycardia may occur see overdosage 4 resistant tachyarrhythmias due to excessive catecholamine action during anesthesia intravenous propranolol is indicated to abolish tachyarrhythmias due to excessive catecholamine action during anesthesia when other measures fail these arrhythmias may arise because of release of endogenous catecholamines or administration of catecholamines all general inhalation anesthetics produce some degree of myocardial depression therefore when propranolol is used to treat arrhythmias during anesthesia it should be used with extreme caution usually with constant monitoring of the ecg and central venous pressure see warnings
Leoni Bücken
2021-06-15T15:54:05.390Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-15T15:54:05.390Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-15T15:54:05.390Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-15T15:54:05.390Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-15T15:54:05.390Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-15T15:54:05.390Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-15T15:54:05.390Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)